Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > Delayed reaction or still no interest

<< Previous

Bullboard Posts

Next >>

Comment by Lee430on Jun 22, 2021 10:37am

92 Views

Post# 33426825

RE:RE:RE:RE:Delayed reaction or still no interest

Thera fell into an IR black hole so no good news can escape the gravitational pull.

Bucknelly21 wrote:

Lee430 wrote: I would definitely load the truck up with as much shares as I could afford after watching that webinar if I wasn’t already over the weight limit…It seems that every time I think Thera has lift off, we end up like the SpaceX Starliner with a RUD event (Rapid Unplanned Disassembly) Back to waiting for the next catalyst.

Bucknelly21 wrote:

Bucknelly21 wrote: Wondering everyone's thoughts? I feel like still no interest, given that I bet 75% of the questions came from this board. Maybe I'm just in a bad frame of mind with Thtx at the moment.

Like I said red...

I think you mean next inhibitor